Loading clinical trials...
Loading clinical trials...
This is an open-label, single treatment study. All subjects will receive 12 months of oral contraceptive therapy with DR-102. Study participants will receive physical and gynecological exams, includin...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
NCT06345586 · Contraception
NCT07115849 · Eumenorrhea, Intrauterine Devices, Medicated, and more
NCT06672016 · Female Contraception
NCT07393334 · Male Contraception, Semen Volume, and more
NCT07365904 · Contraception
Teva Investigational Site 10007
Montgomery, Alabama
Teva Investigational Site 10013
Phoenix, Arizona
Teva Investigational Site 10017
Phoenix, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions